| Filed On | Filing |
|---|---|
| 31 Oct 2022 |
Form 3: Audentes Therapeutics, Inc., 10% owner and 1 other · Taysha Gene Therapies, Inc.
Holds 7,266,342 shares of Common Stock |
| 17 Jul 2019 |
Form 3: Conner Edward R., SVP, Chief Medical Officer
No securities owned |
| 01 Apr 2019 |
Form 3: Meltz Mark A, SVP, General Counsel
Holds 0 shares of No securities beneficially held |
| 04 Jan 2019 |
Form 3: Mosbrooker Eric, SVP, Chief Commercial Officer
Holds 300 shares of Common Stock |
| 13 Dec 2017 |
Form 3: Goldberg Mark Alan, Director
Holds 1,500 shares of Common Stock |
| 13 Jun 2017 |
Form 3: Jarrett Jennifer, Director
Holds 0 shares of No shares of Common Stock are beneficially held |
| 13 Dec 2016 |
Form 3: Smith Julie, Director
Holds 0 shares of No shares of Common Stock are beneficially held |
| 19 Jul 2016 |
Form 3: Woiwode Thomas, Director
Holds 0 shares of No securities beneficially held |
| 19 Jul 2016 |
Form 3: Versant Ventures IV, Llc, 10% owner and 2 others
Holds 0 shares of No securities beneficially held |
| 19 Jul 2016 |
Form 3: Squinto Stephen P, Director
Holds 7,474 shares of Common Stock |
| 19 Jul 2016 | Form 3: Flynn James E, 10% owner and 5 others |
| 19 Jul 2016 |
Form 3: Soloway Thomas P, Senior Vice President, CFO
Holds 0 shares of No securities beneficially held |
| 19 Jul 2016 |
Form 3: Silverstein Jonathan, Director
Holds 224,238 shares of Common Stock |
| 19 Jul 2016 |
Form 3: Schuetz Thomas J., Director
Holds 89,695 shares of Common Stock |
| 19 Jul 2016 |
Form 3: Prasad Suyash, Senior VP & Chief Med Officer
Holds 0 shares of No securities beneficially held |
| 19 Jul 2016 |
Form 3: Patterson Matthew R, Director
Holds 201,814 shares of Common Stock |
| 19 Jul 2016 |
Form 3: Parmar Kush, Director
Holds 0 shares of No securities beneficially held |
| 19 Jul 2016 |
Form 3: Orbimed Advisors Llc, Director and 2 others
Holds 224,238 shares of Common Stock |
| 19 Jul 2016 |
Form 3: Newman Mary, SVP, Regulatory Affairs
Holds 0 shares of No securities beneficially held |
| 19 Jul 2016 |
Form 3: Nagler David, SVP, HR & Corp. Affairs
Holds 0 shares of No securities beneficially held |
Loading...